Protein substitution to produce a processed cheese with high branched-chain amino acids of medical and genetic importance

El-Shazly, Howida A. M.; Awad, Rizk A.; Essawy, Ehab A. Y.; Kamal, Tarek M.; Salama, Wafaa M.
November 2010
Egyptian Journal of Medical Human Genetics;2010, Vol. 11 Issue 2, p121
Academic Journal
Background: The most important metabolic impairment in patients with advanced liver disease is characterized by low levels of circulating branched chain amino acids (BCAAs). The etiology of such abnormal amino acid metabolism is multifactorial including protein restricted diet or inadequate nutritional intake as in protein energy malnutrition. Multiple studies report the beneficial effects of BCAAs supplementation to improve plasma amino acids imbalance, several neurologic diseases, protein energy malnutrition, and subsequently the survival rate of cirrhotic patients. Methods: In the present study we used a protein substitution technique to synthesize a new processed cheese as a dairy source rich in BCAAs, with low phenylalanine content manufactured from Ras cheese, kariesh cheese, butter oil and phenylalanine-free milk. Chemical composition, amino acids analysis, rheological properties and sensory evaluation were done to all of the cheese samples. L-Phenylalanine was selected to induce hepatic and brain affections in Begg Albino strain c (BALB/c) mice model. Effect of 2.5%, 5% and 10% protein-replacement cheese formulas was evaluated among mice groups including histopathological sections of the liver and brain; colorimetric determination for liver enzymes; serum total and differential cholesterol profile, serum albumin, globulin and total protein along with phenylalanine levels determinations. Results: Analysis of the processed cheese sample with 10% protein substitution revealed that the protein content was 7.42 mg/g (about 50% of the content in the standard processed cheese) while fat content, acidity and moisture were nearly the same. The sensory score for all the formulas ranged from 79-88. Highest content of BCAAs along with least phenylalanine content was attained in the processed cheese with 10% protein substitution. Weight of mice fed on different substitution formulas ranged from 22.8 ± 2.2-24.66 ± 2.5 g compared with 17.8 ± 1.9 g in the untreated diseased mice (P< 0.05). Serum phenylalanine was 1.822 ± 0.42 mg/dl in the mice fed on 10% protein substitution formula compared to 6.2± 1.32 mg/dl in the untreated mice (P < 0.01). There was a highly significant difference (P <0.01) between untreated mice and mice fed on 10% substitution cheese formula as regards the serum protein, Aspartate Transaminase (AST) and Alanine Transaminase (ALT). The improvement in histopathological findings was more apparent in the mice fed on 10% formula cheese. Conclusion: The manufactured processed cheese with 10% protein substitution was proved to have a more nutritional therapeutic potential that can help in the implementation of dietary management in many medical and genetic disorders with liver and brain affections.


Related Articles

  • Glial Metabolism of Isoleucine. Radovan Murín; Ghasem Mohammadi; Dieter Leibfritz; Bernd Hamprecht // Neurochemical Research;Jan2009, Vol. 34 Issue 1, p194 

    Abstract  Isoleucine, together with leucine and valine, constitutes the group of branched-chain amino acids (BCAAs). BCAAs are transported from the blood into the brain parenchyma, where they can serve several distinct functions. Since brain tissue is known to oxidatively metabolize BCAAs...

  • Regulation of branched-chain amino acid catabolism: glucose limitation enhances the component of isovalerylspiramycin for the bitespiramycin production. Yong-Hong Wang; Chun-Hai Wu; Ju Chu; Yu-You Hao; Ying-Ping Zhuang; Si-Liang Zhang // Bioprocess & Biosystems Engineering;Feb2010, Vol. 33 Issue 2, p257 

    Abstract  4′′-O-isovalerylspiramycins are the major components of bitespiramycin complex consisting of a group of 4′′-O-acylated spiramycins. The availability of isovaleryl group, usually in vivo derived from leucine, one of the branched-chain amino acids,...

  • Novel metabolic and physiological functions of branched chain amino acids: a review. Shihai Zhang; Xiangfang Zeng; Man Ren; Xiangbing Mao; Shiyan Qiao // Journal of Animal Science & Biotechnology;1/23/2017, Vol. 8, p1 

    It is widely known that branched chain amino acids (BCAA) are not only elementary components for building muscle tissue but also participate in increasing protein synthesis in animals and humans. BCAA (isoleucine, leucine and valine) regulate many key signaling pathways, the most classic of...

  • Catabolism of Branched-Chain Amino Acids in Heart Failure: Insights from Genetic Models. Haipeng Sun; Gang Lu; Shuxun Ren; Jaunian Chen; Yibin Wang // Pediatric Cardiology;Mar2011, Vol. 32 Issue 3, p305 

    Genetic defects in amino acid metabolism are major causes of newborn diseases that often lead to abnormal development and function of the central nervous system. Their direct impact on cardiac development and function has rarely been investigated. Recently, the authors have established that a...

  • Evidence for association of SLC7A9 gene haplotypes with cystinuria manifestation in SLC7A9 mutation carriers. Chatzikyriakidou, Anthoula; Sofikitis, Nikolaos; Kalfakakou, Vasiliki; Siamopoulos, Konstantinos; Georgiou, Ioannis // Urological Research;Oct2006, Vol. 34 Issue 5, p299 

    Cystinuria is a complex genetic disorder. In the present study, we report on the strict linkage disequilibrium of SLC7A9 mutations with the wild type SLC7A9 haplotype of 15 single nucleotide polymorphisms (SNPs) and their effect on cystinuria manifestation and classification. Specifically,...

  • Cystine calculi: challenging group of stones. Ahmed, Kamran; Dasgupta, Prokar; Khan, Mohammad Shamim // Postgraduate Medical Journal;Dec2006, Vol. 82 Issue 974, p799 

    Cystinuria is an autosomal recessive disorder in renal tubular and intestinal transport of dibasic amino acids, which results in increased urinary excretion of cystine, ornithine, lysine and arginine. It affects 1 in 20 000 people and is caused by a defect in the rBAT gene on chromosome 2....

  • The Usefulness of Branched Chain Amino Acids in Patients with Acute or Chronic Hepatic Encephalopathy. Alexander, William F.; Spindel, Enrique; Harty, Richard F.; Cerda, James J. // American Journal of Gastroenterology;Feb1989, Vol. 84 Issue 2, p91 

    Hepatic encephalopathy (HE) is a neuropsychiatric syndrome associated with acute liver failure or chronic parenchymal liver disease. It has been hypothesized that changes in protein and amino acid metabolism and catabolism contribute to the pathogenesis of HE. Clinical investigations into the...

  • Protein Metabolism and Endurance Exercise. Gibala, Martin J. // Sports Medicine;2007, Vol. 37 Issue 4/5, p337 

    Prolonged endurance exercise stimulates whole-body protein turnover (synthesis and degradation) but it remains contentious whether this translates into an increased net protein oxidation or dietary requirement for protein. Skeletal muscle is the major energy consumer during exercise and the...

  • Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. William J. Zinnanti; Jelena Lazovic; Kathleen Griffin; Kristen J. Skvorak; Harbhajan S. Paul; Gregg E. Homanics; Maria C. Bewley; Keith C. Cheng; Kathryn F. LaNoue; John M. Flanagan // Brain: A Journal of Neurology;Apr2009, Vol. 132 Issue 4, p903 

    Maple syrup urine disease (MSUD) is an inherited disorder of branched-chain amino acid metabolism presenting with life-threatening cerebral oedema and dysmyelination in affected individuals. Treatment requires life-long dietary restriction and monitoring of branched-chain amino acids to avoid...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics